C12N 2760/20034
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2760/20034 (Use of virus or viral component as vaccine) appears on 26 US grants and 53 published applications in this corpus.
Search patents in C12N- Granted patents
- 26
- Published applications
- 53
- Assignees
- 37
- Inventors
- 94
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 2 |
| 2008 | 0 | 3 |
| 2009 | 1 | 1 |
| 2010 | 0 | 0 |
| 2011 | 1 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 4 |
| 2016 | 1 | 3 |
| 2017 | 1 | 1 |
| 2018 | 5 | 1 |
| 2019 | 3 | 4 |
| 2020 | 1 | 4 |
| 2021 | 2 | 4 |
| 2022 | 2 | 2 |
| 2023 | 1 | 6 |
| 2024 | 4 | 6 |
| 2025 | 2 | 4 |
| 2026 | 1 | 4 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Influenza virus encoding a truncated NS1 protein and a SARS-CoV receptor binding domain18 Aug 2026US 12,708,663 B2Vivaldi Biosciences Inc.
- Methods of detection and removal of rhabdoviruses from cell lines25 Nov 2025US 12,479,891 B2Takeda Vaccines, Inc.
- Multivalent vaccines for rabies virus and coronaviruses8 Apr 2025US 12,269,155 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Methods of making and using universal centralized influenza vaccine genes20 Aug 2024US 12,064,478 B2NUtech Ventures
- Methods of detection and removal of rhabdoviruses from cell lines25 Jun 2024US 12,018,052 B2Takeda Vaccines, Inc.
- Methods of detection and removal of rhabdoviruses from cell lines30 Jul 2026US 2026/0217770 A1Takeda Vaccines, Inc.
- Compositions and methods for making and using stabilized enveloped viruses by spray-drying and lyophilization2 Apr 2026US 2026/0091106 A1The Regents of the University of Colorado, a body corporate
- Thermostable mucosal vaccine compositions and methods12 Feb 2026US 2026/0041757 A1Global Health Solutions LLC
- Neddylation-activating enzyme inhibitors as viral sensitizers and uses thereof15 Jan 2026US 2026/0015592 A1Ottawa Hospital Research Institute
- Methods of detection and removal of rhabdoviruses from cell lines3 Apr 2025US 2025/0109172 A1Takeda Vaccines, Inc.
Most cited
By later US patents
- Apparatus for releasably holding a socket11US 11,091,778 B22021
- Methods of detection and removal of rhabdoviruses from cell lines4US 10,501,500 B2Takeda Vaccines, Inc. · 2019
- Vaccine compositions comprising a saponin adjuvant3US 10,039,823 B2Glaxosmithkline Biologicals SA · 2018
- Methods of detection and removal of rhabdoviruses from cell lines3US 11,286,282 B2Takeda Vaccines, Inc. · 2022
- Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus2US 10,010,499 B2Georgia Tech Research Corporation · 2018